Stock Earnings

Question 1

Phathom Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Phathom Pharmaceuticals Inc'in toplam varlıkları $378 olup, net loss $-334'dir.

Question 2

PHAT'ün temel finansal oranları nelerdir?

Accepted Answer

Phathom Pharmaceuticals Inc'in cari oranı 0.59, net kâr marjı -607.27, hisse başına satış $0.87'dir.

Question 3

Phathom Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Phathom Pharmaceuticals Inc largest revenue segment is Vonoprazan, at a revenue of 55,252,000 in the most earnings release.For geography, United States is the primary market for Phathom Pharmaceuticals Inc, at a revenue of 55,252,000.

Question 4

Phathom Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Phathom Pharmaceuticals Inc'in net loss $-334'dir.

Question 5

Phathom Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Phathom Pharmaceuticals Inc'in yükümlülüğü 631'dir.

Question 6

Phathom Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Phathom Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 68.51'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	147	55	0	0	0	0
Revenue Growth (YoY)	465%	--	--	--	--	--
Cost of Revenue	18	7	0	--	--	--
Gross Profit	128	47	0	--	--	--
Selling, General & Admin	308	290	117	101	62	27
Research & Development	33	34	49	71	72	98
Operating Expenses	341	324	167	172	135	125
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-274	-334	-201	-197	-143	-129
Income Tax Expense	--	--	--	--	--	--
Net Income	-274	-334	-201	-197	-143	-129
Net Income Growth	-19%	66%	2%	38%	11%	-49%
Shares Outstanding (Diluted)	73.39	63.17	51.28	39.12	30.51	33.23
Shares Change (YoY)	14%	23%	31%	28%	-8%	34%
EPS (Diluted)	-3.74	-5.29	-3.93	-5.05	-4.72	-3.88
EPS Growth	-28.99%	35%	-22%	7%	22%	-62%
Free Cash Flow	-225	-266	-139	-147	-148	-70
Free Cash Flow Per Share	-3.06	-4.21	-2.71	-3.75	-4.85	-2.1
Gross Margin	87.07%	85.45%	0%	--	--	--
Operating Margin	-144.89%	-503.63%	0%	0%	0%	0%
Profit Margin	-186.39%	-607.27%	0%	0%	0%	0%
Free Cash Flow Margin	-153.06%	-483.63%	0%	0%	0%	0%
EBITDA	-213	-277	-167	-172	-135	-125
EBITDA Margin	-144.89%	-503.63%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-213	-277	-167	-172	-135	-125
EBIT Margin	-144.89%	-503.63%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Phathom Pharmaceuticals Inc (PHAT) Price

PHAT Stock Price Chart

PHAT Income

Follow-Up Questions